Pyrimidine-based compounds for the treatment of cancer
US10618905B2 · kind B2 · utility
4Cited by
25References
20Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Dec 21, 2018 |
| Grant date | Apr 14, 2020 |
| Priority date | — |
| Expiry date | Dec 21, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D491/22
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
This invention is in the area of pyrimidine-based compounds for the treatment of disorders involving abnormal cellular proliferation, including but not limited to tumors and cancers.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.